about
Content and quality of websites supporting self-management of chronic breathlessness in advanced illness: a systematic reviewMissing data in randomized controlled trials testing palliative interventions pose a significant risk of bias and loss of power: a systematic review and meta-analysesDoes the use of specialist palliative care services modify the effect of socioeconomic status on place of death? A systematic reviewPatient and health care professional decision-making to commence and withdraw from renal dialysis: a systematic review of qualitative researchA randomised controlled trial of three or one breathing technique training sessions for breathlessness in people with malignant lung disease.Neuroimaging of central breathlessness mechanisms.Palliative care among heart failure patients in primary care: a comparison to cancer patients using English family practice data.Management of cancer-associated thrombosis in people with advanced disease.Preferred and actual place of death in haematological malignancy.Diagnosis and management of people with venous thromboembolism and advanced cancer: how do doctors decide? A qualitative study.The ethical decisions UK doctors make regarding advanced cancer patients at the end of life--the perceived (in) appropriateness of anticoagulation for venous thromboembolism: a qualitative study.Developing a complex intervention for the outpatient management of incidentally diagnosed pulmonary embolism in cancer patients.Does home oxygen therapy (HOT) in addition to standard care reduce disease severity and improve symptoms in people with chronic heart failure? A randomised trial of home oxygen therapy for patients with chronic heart failure.Family Caregivers Who Would Be Unwilling to Provide Care at the End of Life Again: Findings from the Health Survey for England Population Survey.Magnetoencephalography to investigate central perception of exercise-induced breathlessness in people with chronic lung disease: a feasibility pilot.Palliative Radiotherapy in the Presence of Well-Controlled Metastatic Disease after Initial Chemotherapy May Prolong Survival in Patients with Metastatic Esophageal and Gastric Cancer.Clinical decision making in the recognition of dying: a qualitative interview studyBreathlessness and presentation to the emergency department: a survey and clinical record review.Quality of missing data reporting and handling in palliative care trials demonstrates that further development of the CONSORT statement is required: a systematic review.Variations in specialist palliative care referrals: findings from a population-based patient cohort of acute myeloid leukaemia, diffuse large B-cell lymphoma and myelomaBreathlessness in Elderly Adults During the Last Year of Life Sufficient to Restrict Activity: Prevalence, Pattern, and Associated Factors.Management of end stage cardiac failure.The Adaptation, Face, and Content Validation of a Needs Assessment Tool: Progressive Disease for People with Interstitial Lung Disease.Palliative care needs in patients hospitalized with heart failure (PCHF) study: rationale and designThe longitudinal pattern of response when morphine is used to treat chronic refractory dyspneaManagement of venous thromboembolism in patients with advanced cancer: a systematic review and meta-analysis.Review of the evidence for the management of dyspnoea in people with chronic heart failure.Does clinical method mask significant VTE-related mortality and morbidity in malignant disease?Researching breathlessness in palliative care: consensus statement of the National Cancer Research Institute Palliative Care Breathlessness Subgroup.A feasibility study to inform the design of a randomized controlled trial to identify the most clinically and cost effective anticoagulation length with low molecular weight heparin in the treatment of cancer associated thrombosis (ALICAT): study prUpdate on the role of palliative oxygen.Recognizing dying in terminal illness.Gaps in the evidence base of opioids for refractory breathlessness. A future work plan?Interventions to support a palliative care approach in patients with chronic obstructive pulmonary disease: an integrative review.Breathlessness--current and emerging mechanisms, measurement and management: a discussion from an European Association of Palliative Care workshop.Artificial hydration in the terminally ill patient.Prevalence and assessment of breathlessness in the clinical setting.Opioids, Exertion, and Dyspnea: A Review of the Evidence.Change in physiological variables in the last 2 weeks of life: an observational study of hospital in-patients with cancer.A systematic review of strategies used to increase recruitment of people with cancer or organ failure into clinical trials: implications for palliative care research.
P50
Q26745959-81C95CCC-C911-4069-8443-EB5C92ED71CEQ26771540-16BB33C3-146C-4B0B-8879-DC049A13F299Q26795426-4A8EB0E6-A585-4B9A-B238-25C4065A757EQ28085751-6E1100CC-BBE6-4BCB-A5BC-87CA63879CBBQ30663977-8A02224D-B63E-4577-A655-B1AA06DC8A38Q30836748-5A3D0650-46BE-45D3-9689-2136B016808AQ30871770-DB43AAB4-C81F-418D-9752-FFB9A33F84A6Q33414115-484CA3A2-2013-4063-82EE-A669EA96378CQ33886101-DB070E27-1B02-430A-AE54-2746B8B10519Q34346557-7F1BABD2-1810-408C-AC8C-303F7DD23A47Q34402787-B522662C-BBD6-4B2A-9AAF-0A06A9D5B599Q34785968-5059C826-F73E-4F49-AB6C-37D0547FA116Q35783010-3976330D-F9EB-4066-8FF9-8F77C8BC88A0Q35904029-F94BFF3E-ADE6-47FA-98B2-11673CDB8A97Q36070774-00DF0C07-EB94-40C2-AED6-ABA510FFB3C5Q36186967-A2A00F96-8E67-4955-9C70-31D4EDEA2037Q36260397-C0D9BAAD-8638-4631-BF49-0E2C8D8947B5Q36315390-82E1BC1C-3A0D-420B-8CB0-B2F18D050556Q36378102-346F844B-1F48-41D8-BD7A-DECAB15FB734Q36475705-61428871-762E-41AB-B572-48889820B467Q36480641-BDFA1F51-6186-41F3-8B9D-172E503D9543Q36841238-54FFAB11-9317-40F7-95F8-B67E8AEBB9D7Q36882154-8C799D5A-A7DF-4BE3-A42E-ABC65C00732FQ36894841-DAC32FE0-0956-4CEB-87C7-A4CAB7FF0D11Q37032302-0CA9B225-F705-472D-AE21-B15F1DCBD2E1Q37176707-E655DF3C-05D9-4F28-BFD5-F79E4DB62D7CQ37237131-C79E20EB-2B9C-406F-A63C-4E221C0748F2Q37271148-5A648485-527F-44AC-816B-44F367A0C1C5Q37404296-1E4357E0-7400-4E95-BA77-D37BA59D99AEQ37729777-4814A28D-2EF1-41F3-9D1C-07866436C0E9Q37870622-42FCC112-FA7D-426A-8575-443082089774Q37917516-4CCEAF29-10E6-448A-8FD3-19D00EDE41D2Q37979552-82FF3996-E488-4A79-B209-4261B6607989Q37992267-E8438817-D67F-475C-B361-00EA454EEFC7Q38120357-7502E0FC-E2F9-4587-B473-63F8C48C25D4Q38155519-AE0DE8BB-B3BD-4A54-8507-F7DCB46F9BABQ38180711-DD56E0BE-5BA9-4F31-974F-2FA3C91C0095Q38258021-9A14D419-CC68-455B-82DF-687F44B1D478Q38294337-C442EBB9-A14F-4E3A-ABB0-3ED2188947F8Q38302605-89D046E2-CFED-4249-B18B-84171920AA62
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Miriam J Johnson
@ast
Miriam J Johnson
@en
Miriam J Johnson
@es
Miriam J Johnson
@nl
type
label
Miriam J Johnson
@ast
Miriam J Johnson
@en
Miriam J Johnson
@es
Miriam J Johnson
@nl
altLabel
Johnson MJ
@en
prefLabel
Miriam J Johnson
@ast
Miriam J Johnson
@en
Miriam J Johnson
@es
Miriam J Johnson
@nl
P106
P1153
14012989800
57203731753
P21
P31
P4012
P496
0000-0001-6204-9158